A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome

NCT05804669 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Cushing Syndrome
Cushing Disease
Ectopic ACTH Syndrome

Interventions

DRUG: atumelnant

Sponsor

Crinetics Pharmaceuticals Inc.